Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.100
-0.080 (-6.78%)
At close: Jun 27, 2025, 4:00 PM
1.160
+0.060 (5.45%)
After-hours: Jun 27, 2025, 6:56 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $68.14 million as of June 27, 2025. Its market cap has decreased by -69.22% in one year.
Market Cap
68.14M
Enterprise Value
-17.45M
1-Year Change
-69.22%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $68.14M, a decrease of -86.99%. That is a compound annual growth rate of -42.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 70.62M | -23.87% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |